Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNA

Clinical trial NCT05814224 · UNKNOWN

Trial details

NCT number: NCT05814224
Sponsor: Centro di Riferimento Oncologico - Aviano
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Hormone Receptor Positive Breast Carcinoma Breast Neoplasms Neoplasms, Breast Breast Diseases Antineoplastic Agents Aromatase Inhibitors ESR1 Gene Mutation

Start date: 2018-05-22
Primary completion: 2023-12-31
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.